Open Access Open Access  Restricted Access Subscription Access

Neuroprotective Effect of Buchnania Lanzan Leaf Extract in the Management of Alzheimer and Anxiety Disease

Chaturvedi Barkha, Chaturvedi Dev Sharan


Objective: Neuroprotective effect of Buchnania Lanzan Leaf extract in the management of Alzheimer and anxiety disease. Material and Method: In vitro antioxidative analysis for the exploration of the antioxidative properties of Buchnania Lanzan leaf extract was done. To analysis the In vivo antioxidant property of extracts on the oxidative stress induced by the Aluminum Chloride. Albino Wistar rats were administered with AlCl3 at a dose of 4.2mg/kg/day i.p. for 4 weeks. Experimental rats were given Buchnania Lanzan Leaf extract in two different doses of 200mg and 400mg/kg/day orally 1hr before the AlCl3 administration for 4 weeks. At the end of the experiments, aluminum administration significantly decreased the level of GSH and the activities of SOD and increased the level of LPO in brain regions when compared with control rats. Later animal was sacrificed and the brain was taken out and the homogenate was prepared in Tris buffer (pH 7.4) in cold condition and taken for biochemical estimation involving Superoxide dismutase, Lipid peroxide, and Reduced Glutathione test. Results: The Aluminum Chloride cause declination in the level of glutathione, superoxide dismutase and increase in lipid peroxidation which was with the administration of Buchnania Lanzan extract significantly prevented in the brain of rat. Conclusion: Analysis of different biochemical parameters, results indicated the prophylactic action of Buchnania Lanzan extracts against Aluminum Chloride induced oxidative stress in the brain.

Full Text:



Tosato M, Zamboni V, Ferrini A, Cesari M (2007), “The aging process and potential interventions to extend life expectancy”, Clin Interv Aging, Volume 2, Issue 3, pp. 401−412.

Agarwal A, Aponte-Mellado A, Premkumar BJ, Shaman A, Gupta S (2012), “The effects of oxidative stress on female reproduction: a review”, Reprod Biol Endocrinol, Volume 10, Issue 49.

Perry G, Cash AD, Smith MA (2002), “Alzheimer's disease and oxidative stress”, J Biomed Biotechnol, Volume 2, Issue 3, pp. 120−123.

Bolla KI, Briefel G, Spector D, Schwartz BS, Wieler L, Herron J, Gimenez L (1992), Arch. Neurol., Volume 49, pp. 1021–1026.

Yokel RA (2000), Neurotoxicology, Volume 21, pp. 813–828.

Griswold WR, Reznik V, Mendoza SA, Trauner D, Alfrey AC (1983), Pediatrics, Volume 71, pp. 56–58.

Altmann P, Dhanesha U, Hamon C, Cunningham J, Blair J, Marsh F, Lancet ii (1989), pp. 7–12.

Yasui M, Yase Y, Ota K, Mukoyama M, Adachi K (1991), Neurotoxicology, Volume 12, pp. 277–283.

Greger JL, Sutherland JE (1997), Crit. Rev. Clin. Lab. Sci., Volume 34, pp. 439–474.

Exley C (1999), J. Inorg. Biochem., Volume 76, pp. 133–140.

Gulçin I, Elias R, Gepdiremen A, Boyer L (2006), “Antioxidant activity of lignans from a fringe tree (Chionanthus virginicus L.)”, Eur Food Res Technol, Volume 223, pp. 759−767.

Ritesh Jain, Sanmati Kumar Jain (2011), “Total Phenolic Contents and Antioxidant Activities of Some Selected Anticancer Medicinal Plants from Chhattisgarh State, India”, Pharmacologyonline, Volume 2, pp. 755−762,

Ellman GL (1959), Arch. Biochem. Biophys., Volume 82, Issue 1, pp. 70−71.

Robak J, Gryglewski RJ (1998), Biochem Pharmacol, Volume 37, Issue 5, pp. 837−841.

Sohal RS, Mockett RJ, Orr WC (2002), “Mechanisms of aging: an appraisal of the oxidative stress hypothesis”, Free Radical Biol Med., Volume 33, pp. 575–586.


  • There are currently no refbacks.